Mohell N, Dicker A
Wenner-Gren Institute, University of Stockholm, Sweden.
Biochem J. 1989 Jul 15;261(2):401-5. doi: 10.1042/bj2610401.
The effect of CGP-12177, originally developed as a radioligand with antagonist properties for binding studies of beta-adrenergic receptors, was investigated in brown adipose tissue. Contrary to expectations, CGP-12177 showed clear agonist properties in experiments with hamster brown-fat cells, with a maximal effect in stimulating oxygen consumption similar to that of the physiological stimulator noradrenaline, and also with a potency similar to that of noradrenaline [EC50 (50% effective concn.) approx. 70 nM]. This value could be contrasted with the very high affinity of CGP-12177 (KD about 1 nM) for ligand-binding sites on the cells. It is therefore suggested that the high-affinity binding site may not be the one that mediates the CGP-12177-stimulated thermogenesis in isolated cells. Also, when injected into cold-adapted rats, CGP-12177 stimulated non-shivering thermogenesis similarly to noradrenaline. This observation, in conjunction with the reported low general sympathomimetic effect of CGP-12177, may indicate that CGP-12177 could be of interest for the development of anti-obesity drugs.
最初作为具有拮抗剂特性的放射性配体用于β-肾上腺素能受体结合研究而开发的CGP-12177,在棕色脂肪组织中进行了研究。与预期相反,在仓鼠棕色脂肪细胞实验中,CGP-12177表现出明显的激动剂特性,刺激耗氧量的最大效应与生理刺激剂去甲肾上腺素相似,效力也与去甲肾上腺素相似[半数有效浓度(EC50)约为70 nM]。该值与CGP-12177对细胞上配体结合位点的极高亲和力(解离常数KD约为1 nM)形成对比。因此,有人提出高亲和力结合位点可能不是介导CGP-12177刺激离体细胞产热的位点。此外,当注射到冷适应大鼠体内时,CGP-12177刺激非寒战产热的方式与去甲肾上腺素相似。这一观察结果,结合报道的CGP-12177较低的一般拟交感神经效应,可能表明CGP-12177在抗肥胖药物开发方面可能具有价值。